SMS-Based Active Surveillance of Adverse Events following Immunization in Children: The VigiVax Study

Underreporting is the main limitation of spontaneous reporting systems. This cohort-event monitoring study aims to examine the potential of short message service (SMS)-based surveillance compared to traditional surveillance systems. Using VigiVax software, parents of vaccinated children aged two yea...

Full description

Bibliographic Details
Published in:	Vaccines
Main Authors:	Laura Augusta Gonella, Francesca Moretti, Annalisa Capuano, Caterina De Sarro, Lorenza Ferrara, Elisabetta Geninatti, Greta Guarnieri, Xhikjana Hysolakoj, Margherita Lalli, Olivia Leoni, Antea Maria Pia Mangano, Patrizia Marani Toro, Viviana Mecchia, Maria Caterina Merlano, Caterina Palleria, Anna Maria Potenza, Paola Rossi, Marco Rossi, Francesca Sanità, Ester Sapigni, Cristina Scavone, Claudia Sommaro, Marco Tuccori, Giovanna Zanoni, Ugo Moretti, VigiVax Working Group
Format:	Article
Language:	English
Published:	MDPI AG 2024-09-01
Subjects:	active vaccine safety surveillance adverse event following immunization short message services pediatric vaccination patient reporting immunization registries
Online Access:	https://www.mdpi.com/2076-393X/12/9/1076

Similar Items

Intravitreal Anti-VEGF Drugs and Signals of Dementia and Parkinson-Like Events: Analysis of the VigiBase Database of Spontaneous Reports
by: Janet Sultana, et al.
Published: (2020-03-01)

Calcitonin gene-related peptide antagonists in pregnancy: a disproportionality analysis in VigiBase®
by: Roberta Noseda, et al.
Published: (2024-01-01)

Pregabalin Safety in Pregnancy: A Disproportionality Analysis of VigiBase Spontaneous Reporting System
by: Sarah Mondada, et al.
Published: (2025-05-01)

Editorial: Traditional and innovative approaches for signal detection
by: Marco Tuccori, et al.
Published: (2024-02-01)

Influenza Vaccination and Myo-Pericarditis in Patients Receiving Immune Checkpoint Inhibitors: Investigating the Likelihood of Interaction through the Vaccine Adverse Event Reporting System and VigiBase
by: Milo Gatti, et al.
Published: (2021-01-01)

Reporting of late-onset immune-related adverse events with immune checkpoint inhibitors in VigiBase
by: Alessandro Ceschi, et al.
Published: (2024-11-01)

Editorial: Women in science: ophthalmology 2023
by: Menaka C. Thounaojam, et al.
Published: (2024-07-01)

Predicting the response to immunotherapy from gene expression data in HER2-negative breast cancer
by: Caterina A. M. La Porta, et al.
Published: (2025-10-01)

It All Started from a “Web”
by: Cristina Rossi, et al.
Published: (2023-09-01)

Serological Response to SARS-CoV-2 Messenger RNA Vaccine: Real-World Evidence from Italian Adult Population
by: Rosa Papadopoli, et al.
Published: (2021-12-01)

Soft mobility planning for university cities: the case of Pavia
by: Roberto De Lotto, et al.
Published: (2022-01-01)

Can 6-month long regimens become the standardized treatment for MDR-TB globally?
by: Caterina Davoli, et al.
Published: (2025-11-01)

Vigie-Nature : sciences participatives et biodiversité à grande échelle
by: Marine Legrand
Published: (2013-12-01)

Pharmacovigilance in Action: Utilizing VigiBase Data to Improve Clozapine Safety
by: De las Cuevas C, et al.
Published: (2024-11-01)

Infections associated with clozapine: a pharmacovigilance study using VigiBase®
by: Basile Chrétien, et al.
Published: (2023-10-01)

Clinical and Trichoscopic Graded Live Visual Scale for Androgenetic Alopecia
by: Alfredo Rossi, et al.
Published: (2022-05-01)

PAM clustering algorithm based on mutual information matrix for ATR-FTIR spectral feature selection and disease diagnosis
by: Francesca Condino, et al.
Published: (2025-10-01)

The role of ethical climate on teachers’ wellbeing: relationship with psychophysical wellbeing and general health
by: Ivan Borrelli, et al.
Published: (2025-10-01)

The Changing Landscape of Antibiotic Treatment: Reevaluating Treatment Length in the Age of New Agents
by: Francesca Serapide, et al.
Published: (2025-07-01)

Ceftolozane/Tazobactam for Resistant Drugs <i>Pseudomonas aeruginosa</i> Respiratory Infections: A Systematic Literature Review of the Real-World Evidence
by: Luca Gregorio Giaccari, et al.
Published: (2021-05-01)

Palabras de Alejandro Rossi y Alberto Moretti
by: Alejandro Rossi, et al.
Published: (2019-01-01)

Characteristics of adverse reactions of three anti-glioma drugs in WHO-VigiAccess
by: Huadong Ke, et al.
Published: (2024-10-01)

Quality of the FarmaVigiC database filling process, Las Tunas 2021
by: Sahily Rojas-Pérez, et al.
Published: (2023-11-01)

The completeness of adverse drug reaction reports in South Africa: An analysis in VigiBase®
by: Mafora F. Matlala, et al.
Published: (2023-01-01)

Short communication: Comments on hair disorders associated with dupilumab based on VigiBase
by: Sunny Park, et al.
Published: (2022-01-01)

La Biennale del Paesaggio Mediterraneo
by: Francesca Moretti
Published: (2015-11-01)

Correction: Rania et al. Efficacy and Safety of Intra-Articular Therapy with Cross-Linked Hyaluronic Acid in Patients with Knee Osteoarthritis. <i>Pharmaceuticals</i> 2025, <i>18</i>, 302
by: Vincenzo Rania, et al.
Published: (2025-07-01)

Efficacy and Safety of Intra-Articular Therapy with Cross-Linked Hyaluronic Acid in Patients with Knee Osteoarthritis
by: Vincenzo Rania, et al.
Published: (2025-02-01)

Exploring Sangelose-cyclodextrin in situ-forming hydrogels for vitreous substitution: design, development, and characterization
by: Gaia Zucca, et al.
Published: (2025-09-01)

Lichen Amyloidosis in an Atopic Patient Treated with Dupilumab: A New Therapeutic Option
by: Benedetta Tirone, et al.
Published: (2024-05-01)

Case report: A relevant misdiagnosis: Photosensitive epilepsy mimicking a blinking tic
by: Francesca Burlo, et al.
Published: (2022-11-01)

Correlation between visual field index and quality of life in glaucoma patients: a new tool to screen quality of life perception?
by: Gemma Caterina Maria Rossi, et al.
Published: (2023-09-01)

Comparative Efficacy and Safety of Two Different Formulations of Linear Hyaluronic Acid in Patients with Knee Osteoarthritis
by: Vincenzo Rania, et al.
Published: (2025-07-01)

Characteristic analysis of adverse reactions of histone deacetylase inhibitors based on WHO-VigiAccess
by: Tongnan Yin, et al.
Published: (2025-03-01)

Characteristic analysis of adverse reactions of finerenone: an in-depth analysis from WHO-VigiAccess
by: Hongxuan Fan, et al.
Published: (2025-08-01)

A VigiBase Descriptive Study of Fluoroquinolone-Associated Peripheral Nervous System Disorders
by: Madalina Huruba, et al.
Published: (2022-01-01)

Panorama das notificações de eventos adversos a medicamentos manipulados no Brasil após implementação do VigiMed
by: Caroline Albert Valerio, et al.
Published: (2024-09-01)

A new information tool as an enabling technology: application and simulation
by: Francesca Ciampa, et al.
Published: (2023-05-01)

Potenzialità dell’esercizio fisico nel miglioramento della sintomatologia dell’ADHD
by: Francesca Caso, et al.
Published: (2022-01-01)

Labor exploitation in the Italian agricultural sector: the case of vulnerable migrants in Tuscany
by: Caterina Francesca Guidi, et al.
Published: (2023-10-01)